Meperidine (Demerol) Market, By Form (Tablet, Injection, and Syrup), By Application (Anesthesia, Cough Treatment, and Diarrhea Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North Americ

Meperidine (Demerol) Market, By Form (Tablet, Injection, and Syrup), By Application (Anesthesia, Cough Treatment, and Diarrhea Treatment), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Meperidine is an opioid pain medication. An opioid is sometimes referred to as narcotics. Meperidine acts on the central nervous system (CNS) to relieve pain. Several physicians prefer to prescribe Meperidine for the treatment of acute and chronic severe pain as it has lesser risk of addiction and is safer than morphine. Meperidine should not be used to treat long-term or ongoing pain. It should only be used to treat sudden episodes of moderate to severe pain. This medicine is available only under a restricted distribution program called the Opioid Analgesic REMS (Risk Evaluation and Mitigation Strategy) program. Meperidine is available under the following different brand names: Demerol and Pethidine. Demerol comes in tablet or liquid forms. The tablets are circular in shape, white in color, and come in 50 mg or 100 mg strengths. As a liquid, Demerol comes in a syrup or as an injectable solution
Market Dynamics
Increasing surgical procedures and increasing prevalence of cancer is expected to drive the growth of global Meperidine (Demerol) market over the forecast period. For instance, according to JCO Global Oncology, an American Society of Clinical Oncology Journal, it is estimated that projected incidence of patients with cancer for the year 2021 in India in males is 679,421 and in females is 712,758. Furthermore, increasing number of surgeries worldwide is expected to support the growth of the market during the forecast period. For instance, according to Eurostat, 2019, there were at least 1.4 million caesarean sections performed in the EU in 2017.
Key features of the study:
This report provides in-depth analysis of the global Meperidine (Demerol) market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Meperidine (Demerol) market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., Vintage Pharmaceuticals, Inc., and Sanofi
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Meperidine (Demerol) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Meperidine (Demerol) market
Detailed Segmentation:
Global Meperidine (Demerol) Market, By Form :
Tablet
Injection
Syrup
Global Meperidine (Demerol) Market, By Application :
Anesthesia
Cough Treatment
Diarrhea Treatment
Global Meperidine (Demerol) Market, By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Meperidine (Demerol) Market, By Region:
North America
By Form
Tablet
Injection
Syrup
By Application
Anesthesia
Cough Treatment
Diarrhea Treatment
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Form
Tablet
Injection
Syrup
By Application
Anesthesia
Cough Treatment
Diarrhea Treatment
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Form
Tablet
Injection
Syrup
By Application
Anesthesia
Cough Treatment
Diarrhea Treatment
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Form
Tablet
Injection
Syrup
By Application
Anesthesia
Cough Treatment
Diarrhea Treatment
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Form
Tablet
Injection
Syrup
By Application
Anesthesia
Cough Treatment
Diarrhea Treatment
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Form
Tablet
Injection
Syrup
By Application
Anesthesia
Cough Treatment
Diarrhea Treatment
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
South Africa
Central Africa
North Africa
Company Profiles
Pfizer, Inc.
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Hikma Pharmaceuticals USA Inc.
Epic Pharma, Inc.
Vintage Pharmaceuticals, Inc.
Sanofi
“*” marked represents similar segmentation in other categories in the respective section.